The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1376
Drugs for Ovulation Induction
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Infertility occurs in about 15% of couples. About one-third of cases are due to problems with ovulation or other female factors, another third are due to a male infertility factor, and the remaining third are unexplained. In older women, unexplained infertility is probably caused by diminished quality and quantity of oocytes. The first approach to treatment of female-factor infertility generally is the use of drugs that stimulate oocyte production.

NORMAL OVULATION — Pulsatile release of gonadotropin releasing hormone (GnRH) from the hypothalamus initiates a normal menstrual cycle. GnRH stimulates pituitary release of the endogenous gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH), which act on the ovary to stimulate oocyte growth. A rapid increase in LH concentrations midcycle (about day 14), the "LH surge", triggers ovulation. Fertilization usually occurs 24-36 hours ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Ovulation Induction
Article code: 1376b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian